Access cutting-edge pulmonary hypertension treatment through this clinical trial at a research site in St Petersburg. Study-provided care at no cost to qualified participants.
Access pulmonary hypertension specialists in St Petersburg at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary hypertension treatment provided free
The investigators' central hypothesis is that early combination therapy with two PAH-specific oral therapies that have been shown to be well tolerated in the pediatric population, sildenafil and bosentan, will result in better World Health Organization (WHO) functional class at 12 months after initiation of PAH treatment than therapy with sildenafil alone.
Sponsor: Johns Hopkins University
Check if you qualify for this pulmonary hypertension clinical trial in St Petersburg, FL
If you're searching for pulmonary hypertension treatment options in St Petersburg, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Petersburg research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.